Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines

Update Il y a 4 ans
Reference: NCT01270503

Woman and Man

Extract

This aim of the study is to assess post-marketing safety of a single dose of Menactra® vaccine with the intent to support conversion from monitored release to initial registration of Menactra® vaccine in the Philippines. Primary Objective: To describe the serious adverse events occurring within 30 days among participants who have received one dose of Menactra® vaccine.


Inclusion criteria

  • Meningitis ,Meningococcal Disease

Links